Pharmacolog i Uppsala AB (publ) announces that the company’s new hardware platform is now available for sale. The new platform, together with an updated software version, will form the basis for Pharmacolog’s SaaS model.
The platform was presented earlier this year at the annual congress organized by The European Association of Hospital Pharmacists (EAHP). Both DrugLog™ and PrepLog™, which are used for quality control of compounded pharmaceuticals in hospital pharmacies, are now available for sale on the new hardware platform, which above all offers improved performance and user experience.
In connection with the start of sales of the new hardware platform, Pharmacolog is also launching updated software, version 4.10, for all instruments in the product portfolio. The new software version offers improved management of calibrations that Pharmacolog provides for a large number of substances and is available to all customers regardless of the version of measuring instrument they use. Software version 4.10 also forms the basis for the updated sales strategy with recurring revenue through a SaaS (Software a Service) model. Initially, this model will be offered to customers who select DrugLog™ or PrepLog™ on the new hardware platform.
Lars Gusch, CEO of Pharmacolog comments: “The pieces fall into place for Pharmacolog. The new hardware platform enables higher production volumes and ensures future delivery of critical components. We are also launching a new software version to improve the customer experience and prepare for the implementation of our new sales strategy. It will be an exciting year as we introduce our in-demand SaaS offering this summer.”
Pharmacolog provides solutions and products that enhance work efficiency and safety when preparing injectable medication. Our goal is to help prevent medication errors and ensure maximum medication efficacy when treating patients with powerful yet potentially harmful injectable drugs. Pharmacolog’s products help staff at pharmacies and hospital wards minimize the risk of errors in the compounding process. Furthermore, by verifying that drugs and narcotics used in surgery have not been tampered with, our solutions also make a vital contribution to preventing drug diversion.